EBEva-Lotta Brakemeier

Eva-Lotta Brakemeier

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eva-Lotta Brakemeier has a total of 291 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Forest|Health: a pilot study on feasibility and exploratory outcomes of a modular forest therapy intervention in Mecklenburg-Western Pomerania

    by Ann-Kristin Reinhard, Sophie Hauck, Kristin Lehnert, Bernhard Lehnert, Eva-Lotta Brakemeier, Susanne Wurm

    Introduction: Nature-based interventions aimed at promoting health, enhancing well-being and supporting medical treatment have long been a focus of public health research. In particular, forest therapy and forest bathing are well established in Asia as evidence-informed approaches to stress reduction. In Europe, research on forest therapy is expanding although the field remains comparatively young. Existing studies have mainly focused on the short-term effects of single forest visits while evidence on multiweek interventions and potential medium-term to long-term effects remains limited. The project Forest|Health ( Wald|Gesund ), embedded within the research consortium T!Raum-Initiative One-Health-Region Pomerania located in northern Germany, aims to address this gap by developing a structured forest therapy intervention tailored to three different target groups. Methods and analysis: The study protocol describes a pilot study to evaluate a modular forest therapy intervention with regard to feasibility indicators as well as stress-related and symptom-related exploratory outcomes. A total of 120 participants will be recruited across three target groups: community-dwelling adults aged 65 years and older, adults with arterial hypertension and adults with depressive symptoms recruited from treatment waiting lists. Using a multimethod approach, two preliminary studies were conducted: a survey of community-dwelling individuals in the region and focus groups with regional stakeholders. Additionally, a 2-week pilot study of the intervention was conducted. Based on these findings, a 4-week modular forest therapy intervention will be implemented. Participants will be assigned to intervention modules with distinct content using a quasi-randomised procedure. The intervention will follow a pre–post design with follow-up assessments. Feasibility indicators will be assessed as key process outcomes. The primary exploratory outcome will be stress while secondary exploratory outcomes will include psychological and physiological health-related measures. Ethics and dissemination: The study was approved by the Ethics Committee of the University Medicine Greifswald. Participants will provide informed consent, receive information about potential risks and support options. The results will be disseminated through scientific publications, conferences and public outreach. Trial registration: This study protocol is preregistered on the Open Science Framework (OSF; Registration DOI: 10.17605/OSF.IO/C2D5P; last update 16 December 2025).

  • Open Access

    Large Language Model–Based Behavioral Activation Chatbot for Young People With Depression Using Artificial Users and Clinical Experts: Mixed Methods Evaluation

    by Florian Onur Kuhlmeier, Leon Hanschmann, Melina Rabe, Stefan Lüttke, Eva-Lotta Brakemeier, Alexander Maedche

    Background: Mental health chatbots are increasingly used to support people with depressive symptoms, and large language models make these systems more flexible than rule-based chatbots. However, it remains unclear how well large language model–based chatbots deliver structured psychological interventions. Objective: This study examined how well a GPT-4o–based chatbot delivered a behavioral activation intervention for young people with depression using sessions with artificial users and clinical expert assessment. It also identified limitations and potential refinements. Methods: We implemented a GPT-4o (gpt-4o-2024-08-06; OpenAI)–based chatbot using a structured system prompt to deliver a single-session behavioral activation intervention for people with depression aged 14 to 29 years. We generated 48 sessions with GPT-4o–based artificial users derived from clinical vignettes varying across 7 characteristics. Ten clinical experts, either licensed psychotherapists or advanced psychotherapy trainees, independently assessed the sessions using the 14-item Quality of Behavioral Activation Scale (Q-BAS), rated from 0 to 6, supplemented by rating therapeutic capabilities, artificial user authenticity and difficulty, and qualitative feedback. Results: The chatbot completed all 7 intervention phases in every session. The mean holistic session quality rating was 3.94 (SD 1.23), and the mean Q-BAS rating was 4.03 (SD 1.18). Thirteen of 14 Q-BAS components exceeded the satisfactory threshold of 3. Ratings were highest for mood assessment (mean 5.42, SD 1.09) and activity planning (mean 4.98, SD 1.41) and lowest for explaining positive reinforcement (mean 2.92, SD 2.30) and supporting activity-mood monitoring (mean 3.02, SD 2.04). Therapeutic capability ratings were highest for message safety (mean 5.90, SD 0.37), message clarity (mean 5.56, SD 0.77), and objective, nonjudgmental communication (mean 5.17, SD 1.04) and lowest for therapeutic rapport (mean 4.12, SD 1.45) and natural conversation flow (mean 4.25, SD 1.42). Artificial users were rated below the scale midpoint for authenticity (mean 2.75, SD 1.41) and difficulty (mean 1.23, SD 1.46). Clinical experts described the chatbot as structured, clear, and safe but identified insufficient clinical reasoning as the main limitation, particularly in evaluating the therapeutic suitability and feasibility of activities, barriers, solution strategies, and rewards. Artificial users were often highly compliant, especially when identifying positive activities. Conclusions: In expert-rated sessions with artificial users, the chatbot delivered the behavioral activation intervention as intended and performed strongest on procedural components. It performed less well on positive reinforcement and activity-mood monitoring, indicating refinement needs in clinical reasoning, follow-up questioning, and evaluating whether proposed activities, plans, barriers, solution strategies, and rewards are therapeutically appropriate and feasible. The findings identify targets for improvement before testing with human users, while the artificial user design and expert ratings limit conclusions about real therapeutic interactions.

  • Situationsanalyse

    by Anne Guhn, Eva-Lotta Brakemeier

  • Interpersonelle Diskriminationsübung

    by Anne Guhn, Eva-Lotta Brakemeier

  • Open Access

    The effects of introducing measurement-based care in outpatient psychotherapy: a naturalistic study

    by Tim Kaiser, Selin Demir, Eva-Lotta Brakemeier

    Objective. This study investigated the effectiveness of a newly implemented routine outcome monitoring and feedback system, the Greifswald Psychotherapy Navigation System (GPNS). Methods. 261 patients (M_age = 33 years, 79% female) completed individual cognitive-behavioral therapy (CBT) from 61 psychotherapists. Using Bayesian instrumental variable estimation, we estimated the local average treatment effect (LATE) of using the GPNS on post-treatment symptom severity and personality impairment. Sensitivity analyses were performed to estimate the robustness of our estimates.Results. Using the GPNS significantly reduced post-treatment symptom severity (LATE = -0.11, 95% CrI: -0.18; -0.03) and personality impairment (LATE = -2.65, 95% CrI: -3.72; -1.58). Sensitivity analyses showed that the effects were robust to plausible residual confounding. Conclusion. The GPNS shows promise for improving outcomes of CBT. Future prospective trials should be conducted to obtain a more generalizable estimate of its effect.

  • Open Access

    The effects of introducing measurement-based care in outpatient psychotherapy: a naturalistic study

    by Tim Kaiser, Selin Demir, Eva-Lotta Brakemeier

    Objective. This study investigated the effectiveness of a newly implemented routine outcomemonitoring and feedback system, the Greifswald Psychotherapy Navigation System (GPNS).Methods. 261 patients (M_age = 33 years, 79% female) completed individual cognitive-behavioral therapy (CBT) from 61 psychotherapists. Using Bayesian instrumental variableestimation, we estimated the local average treatment effect (LATE) of using the GPNS onpost-treatment symptom severity and personality impairment. Sensitivity analyses wereperformed to estimate the robustness of our estimates.Results. Using the GPNS significantly reduced post-treatment symptom severity (LATE = -0.11, 95% CrI: -0.18; -0.03) and personality impairment (LATE = -2.65, 95% CrI: -3.72; -1.58). Sensitivity analyses showed that the effects were robust to plausible residualconfounding.Conclusion. The GPNS shows promise for improving outcomes of CBT. Future prospectivetrials should be conducted to obtain a more generalizable estimate of its effect.

  • Open Access

    Digital crisis counseling during wartime: Pre–post outcomes and user experience in Ukrainian and German samples

    by Ekaterina Reymarova, Gunther Meinlschmidt, Lars Kuchinke, Melanie Eckert, Shadi Saee, Kateryna Bondar, Moritz Borrmann, Richard Wundrack, Christine Rummel-Kluge, Eva-Lotta Brakemeier, et al.

  • Open Access

    Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial

    by Eva-Lotta Brakemeier, Jan Philipp Klein, Johannes Zimmermann, Maike Hollandt, Matthias A Reinhard, Sabrina Boger, Luisa Daldrup, Luk Eldem, Philippa Gebhardt, Susanne Heinrich, et al.

    Introduction: Up to 30% of individuals with depression develop persistent depressive disorder (PDD), an often disabling and difficult to treat condition. The Cognitive Behavioural Analysis System of Psychotherapy (CBASP) is the only psychotherapy developed specifically for treating individuals with PDD. While several randomised controlled trials (RCTs) have demonstrated its efficacy in outpatient settings, evidence for its use in inpatient settings remains limited. Pilot studies of CBASP inpatient programmes in Germany have shown promising feasibility and effectiveness; however, no RCTs to date have systematically evaluated their outcomes. This study represents the first RCT to compare the short- and long-term efficacy and safety of CBASP with Behavioural Activation (BA), a first-line psychotherapy for depression, within an intensive multimodal inpatient setting. Methods and analysis: In this prospective, multicentre, rater-blinded RCT with an active control group, we aim to recruit 396 adults (aged 18–70 years) with treatment-resistant PDD at eight German university hospitals. Participants will be randomly assigned to receive either (1) CBASP or (2) BA within an intensive treatment programme consisting of 10 weeks acute treatment in an inpatient and/or day clinic setting, followed by 6 weeks of outpatient continuation treatment. Primary and secondary outcome assessments will be conducted at multiple time points: baseline (T0), treatment onset (T1), after 5 and 10 weeks of acute treatment (T2, T3), at the end of continuation treatment (T4, week 16) and every 2 months up to week 64 (T5, naturalistic follow-up). The primary outcome measure will be the change in depression severity, as assessed by the Hamilton Depression Rating Scale (24-item version), after 16 weeks of treatment (from T0 to T4). Secondary outcomes will include response, remission, deterioration and relapse rates, self-reported depression and anxiety symptoms and additional psychological variables. A cost-benefit analysis will evaluate the health-economic benefits of both interventions. Additionally, this RCT will explore personalised treatment selection and mechanisms of change, including potential moderators and mediators of treatment effects. The findings from this trial are expected to provide clinicians with evidence-based guidance on choosing CBASP versus BA for inpatients with treatment-resistant PDD. Ethics and dissemination: This study has received ethical approval from the ethics committees of all participating university hospitals. All participants will provide written informed consent before enrolment. Study findings will be published in peer-reviewed journals and presented at national and international conferences. We have involved people with lived experience from the earliest pilots onward, using their feedback to refine our study design. Ongoing consultation at conferences and public events has further ensured that our research remains grounded in patient perspectives. Trial registration number: NCT04996433 .


  • Open Access

    A Large Language Model-Based Behavioral Activation Chatbot for Young People with Depression: Mixed-Methods Evaluation Using Artificial Users and Clinical Experts (Preprint)

    by Florian Onur Kuhlmeier, Leon Hanschmann, Melina Rabe, Stefan Lüttke, Eva-Lotta Brakemeier, Alexander Maedche

    BACKGROUND Depression affects over 280 million people globally; nevertheless, access to evidence-based psychotherapy remains severely limited by workforce shortages and stigma. Large language model (LLM)-based chatbots promise to overcome the rigidity of rule-based systems; however, their ability to deliver structured psychological interventions with clinical fidelity remains largely unverified. Unlike psychotherapists, who undergo rigorous fidelity assessments using validated clinical instruments, LLM-based chatbots have not been subjected to equivalent evaluation standards. OBJECTIVE This study aimed to evaluate the clinical fidelity of an LLM-based chatbot delivering behavioral activation for depression to young people and to identify limitations and opportunities for refinement through clinical expert assessment. METHODS We developed an LLM-based chatbot (GPT-4o) by implementing a seven-phase behavioral activation protocol for young people aged 14–29 years with depressive symptoms. We created 48 artificial users (GPT-4o) derived from clinical patient vignettes, systematically varied across seven characteristics, including depression severity, gender, and attitudes toward mental health chatbots. Ten licensed psychotherapists or advanced psychotherapy trainees (mean age 30.1 years, SD 4.12; 70% female) independently assessed sessions using the Quality of Behavioral Activation Scale (Q-BAS), a validated 14-item fidelity instrument (0–6 scale; ≥3 indicates satisfactory delivery), supplemented by therapeutic capability ratings and qualitative feedback. RESULTS The chatbot completed all seven intervention phases across all 48 sessions. The mean holistic session quality rating was 3.94 (SD 1.23) and the mean Q-BAS rating was 4.03 (SD 1.18). Thirteen of the 14 components exceeded the satisfactory threshold. Component adequacy rates ranged from 97.9% for mood assessment (n=47/48) to 56.2% for explaining positive reinforcement (n=27/48). The highest-rated components were mood assessment (M=5.42, SD=1.09) and planning activities (M=4.98, SD=1.41); the lowest were explaining positive reinforcement (M=2.92, SD=2.30) and encouraging observation of activity–mood connections (M=3.02, SD=2.04). Variance decomposition showed that 36.8% of the Q-BAS variance was attributable to session differences (variance=1.27, 95% CI 0.82–2.02) and 12.0% to component differences (variance=0.42, 95% CI 0.18–0.98). Message safety received the highest therapeutic capability rating (M=6.90, SD=0.37), with 92% of sessions rated at maximum. Therapeutic rapport received the lowest rating (M=5.13, SD=1.45). Artificial users with negative chatbot attitudes were rated as significantly more authentic than those with positive attitudes (W=387.50, p=.036), without significantly affecting fidelity scores (p=.275). Qualitatively, psychotherapists consistently identified insufficient clinical reasoning as the primary limitation, particularly the failure to verify whether activities and rewards were therapeutically appropriate. CONCLUSIONS Although large language model-based chatbots can execute structured therapeutic protocols with satisfactory fidelity while maintaining high message safety, clinical reasoning remains a critical gap. Prompt-level refinements, including granular task breakdown, template-based content, embedded clinical decision rules, and explicit redirection mechanisms, were proposed to address the identified shortcomings.

  • Open Access

    Beyond Symptom Reduction: The Causal Effect of Cognitive Behavioral Therapy on Interpersonal Problems

    by Jonas Hallgans, Stephan Bartholdy, Tim Kaiser, Marit Kristine List, Eva-Lotta Brakemeier

    Objective: Interpersonal problems are important transdiagnostic features in the development and treatment of mental disorders. However, evidence on causal effects of cognitive behavioral therapy (CBT) and differential treatment effects on interpersonal problems is scarce. Therefore, this study examines whether modern routine outpatient CBT more strongly reduces interpersonal problems than a naturalistic waitlist control condition. Potential heterogeneity of treatment effects is inspected, specifically focusing on differences in childhood emotional neglect and abuse. Method: Using observational data of outpatients with various mental disorders at three measurement points (intake on a waitlist, pre- and post-therapy assessments), we construct two treatment arms (NCBT = 256 vs. Nwaiting condition = 431) and train a Causal Forest to estimate treatment effects on interpersonal problems, given observed covariates. Results: Our results indicate a robust, moderate effect of CBT on interpersonal problems while fostering a dominant interpersonal style. Neither broad nor specific tests of heterogeneity indicate differential treatment effects. Conclusion: Although the findings are subject to methodological limitations and should be interpreted cautiously, they provide preliminary evidence that CBT may be an effective and broadly applicable treatment for interpersonal problems. Future randomized controlled trials are needed to confirm these results and establish causal inference.